Lee Golden
Förmögenhet: 7 M $ per 2026-06-30
Förmögenhet: 7 M $ per 2026-06-30
Dr. Lee S.
Golden, MD, is an Independent Director at Cadrenal Therapeutics, Inc. and a Chief Medical Officer & Executive Vice President at PTC Therapeutics, Inc. He is on the Board of Directors at Cadrenal Therapeutics, Inc. Dr. Golden was previously employed as a Chief Medical Officer by Espero Pharmaceuticals, Inc., a Chief Medical Officer by Gemphire Therapeutics, Inc., a Head-Pulmonary by Mesoblast Ltd., a Head-Cardiovascular & Blood Disorders by Eisai, Inc., a Senior Director-US Medical by Actelion Pharmaceuticals US, Inc., and a Medical Director by Pfizer Inc. He also served on the board at Coagulation Sciences LLC.
He received his undergraduate degree from the University of Michigan and a doctorate degree from New York University School of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-10 | 79 964 ( 0,1 % ) | 7 M $ | 2026-06-30 | |
| 2026-07-27 | 1 667 ( 0,06 % ) | 5 568 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| PTC THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-01-01 |
| CADRENAL THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2025-11-24 |
| Företag | Position | Slut |
|---|---|---|
Espero Pharmaceuticals, Inc.
Espero Pharmaceuticals, Inc. Medical DistributorsDistribution Services Manufactures and supplies drugs related to cardiovascular | Teknisk/Vetenskaplig/F&U Direktör | 2020-05-01 |
| METAVIA INC. | Teknisk/Vetenskaplig/F&U Direktör | 2018-09-18 |
| MESOBLAST LIMITED | Företagsledare/Principal | 2016-10-01 |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Företagsledare/Principal | 2011-07-01 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Företagsledare/Principal | 2008-03-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
PTC Therapeutics, Inc.
PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mesoblast Ltd.
Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Health Technology |
New York University School of Medicine
New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coagulation Sciences LLC
Coagulation Sciences LLC Medical/Nursing ServicesHealth Services Provides blood-testing solutions | Health Services |
Gemphire Therapeutics, Inc.
Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for the treatment of Dyslipidemia | Health Technology |
Espero Pharmaceuticals, Inc.
Espero Pharmaceuticals, Inc. Medical DistributorsDistribution Services Manufactures and supplies drugs related to cardiovascular | Distribution Services |
Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapy with orphan drug indication | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån